Amber Yasmeen

ORCID: 0000-0002-7445-3032 · 2 papers in corpus

diagnostic-accuracy 2023

GD2 and GD3 gangliosides as diagnostic biomarkers for all stages and subtypes of epithelial ovarian cancer

Frontiers in oncology ·doi:10.3389/fonc.2023.1134763

BACKGROUND: Ovarian cancer (OC) is the deadliest gynecological cancer, often diagnosed at advanced stages. A fast and accurate diagnostic method for early-stage OC is needed. The tumor marker gangliosides, GD2 and GD3, exhibit properties th…

diagnostic-accuracy 2012

Combination of Serum Biomarkers to Differentiate Malignant From Benign Ovarian Tumours

·doi:10.1016/s1701-2163(16)35273-2

ObjectiveTo investigate biomarkers and clinical parameters to distinguish ovarian cancers from benign ovarian tumours.MethodsSerum biomarkers (CA 125, human epididymis protein 4 [HE 4], interleukin-18 [IL-18], leptin, macrophage migration i…